ENOV News and Press, Enovis Corporation From 04/14/24

2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...

2024-03-31 19:46:03 ET More on Alphatec, Enovis Corporation, etc. IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF Alphatec Holdings, Inc. (ATEC) Q4 2023 Earnings Call Transcript Enovis Corporation (ENOV) Q4 2023 Earnings Call Trans...

2024-03-28 12:39:10 ET Read the full article on Seeking Alpha For further details see: NXST, GNTX, and COKE among the best mid-cap technical ideas - Roth MKM

Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced that management will participate in the upcoming 23rd Annual Needham Virtual Healthcare C...

2024-03-22 05:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Wilmington, DE, April 13, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2023 financial results on Thursday, May 4, 202...

2023-04-04 04:02:41 ET Summary Jeff Smith’s 13F portfolio value increased from $4.55B to $5.22B this quarter. Starboard Value added Salesforce and increased GoDaddy while decreasing Commvault Systems and dropping Huntsman Corp. The largest three individual stock positio...

2023-04-03 07:21:21 ET Enovis ( NYSE: ENOV ) announced a definitive agreement to acquire Novastep, a subsidiary of Amplitude Surgical, and global developer of clinically proven foot and ankle solutions. The transaction is expected to close in Q2 of 2023. A leading...

Wilmington, DE, April 03, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced a definitive agreement to acquire Novastep®, a subsidiary of Amplitude Surgical SA (Paris: AMPLI), and global developer of clin...

2023-03-15 16:39:47 ET Medical technology company Enovis ( NYSE: ENOV ) appointed CEO Matt Trerotola to the additional position of board chair, effective following the May 16 annual meeting of stockholders. Current Chair Mitchell Rales will retire on the same day...